Skip to main content
Sage Therapeutics, Inc. (SAGE)
NASDAQ: SAGE · Real-Time Price · USD
6.64
-0.35 (-5.01%)
At close: Oct 4, 2024, 4:00 PM
6.66
+0.02 (0.36%)
After-hours: Oct 4, 2024, 4:06 PM EDT

Sage Therapeutics Revenue

Sage Therapeutics had revenue of $8.65M in the quarter ending June 30, 2024, with 249.80% growth. This brings the company's revenue in the last twelve months to $97.24M, up 837.55% year-over-year. In the year 2023, Sage Therapeutics had annual revenue of $86.46M with 1,024.84% growth.

Revenue (ttm)
$97.24M
Revenue Growth
+837.55%
P/S Ratio
4.11
Revenue / Employee
$199,678
Employees
487
Market Cap
405.37M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202386.46M78.77M1,024.84%
Dec 31, 20227.69M1.38M21.85%
Dec 31, 20216.31M-1.11B-99.43%
Dec 31, 20201.11B1.11B16,123.06%
Dec 31, 20196.87M-83.41M-92.39%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cross Country Healthcare 1.58B
Organogenesis Holdings 448.39M
Canopy Growth 209.77M
Talkspace 172.54M
GRAIL 109.74M
Theravance Biopharma 62.02M
MaxCyte 45.44M
Jin Medical International 20.13M
Revenue Rankings

SAGE News

More News